Fennec Pharmaceuticals (FENC) executive compensation, 2026 proxy

Jeffrey Hackman, CEO, was paid $1.7M in 2025, up 7% from $1.6M the year before.

Filed
April 28, 2026
Annual meeting
June 10, 2026
Pay year
2025
Named executives
3
CEO total pay
$1.7M+7% vs prior year
CEO Salary
$586,343For fiscal 2025
CEO Total Compensation
$1,722,154Up from prior year
CFO Total Compensation
$1,873,024Robert Andrade

How Hackman was paid

$1.7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Named executive officers

ExecutiveTotal
Jeffrey HackmanCEO$1,722,154
Robert AndradeCFO$1,873,024
Pierre S. SayadCMO$775,081

What changed and why

  • $1.7MCEO Jeffrey Hackman received total compensation of $1,722,154 for fiscal 2025.
  • $586KSalary for CEO Jeffrey Hackman increased to $586,343 from $225,000 in the prior year.
  • $887KStock awards granted to the CEO totaled $887,100 including restricted and performance share units.
  • $203KOption awards for the CEO were valued at $202,878 in grant date fair value.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.